000 | 01854 a2200505 4500 | ||
---|---|---|---|
005 | 20250516130540.0 | ||
264 | 0 | _c20131023 | |
008 | 201310s 0 0 eng d | ||
022 | _a1600-0463 | ||
024 | 7 |
_a10.1111/apm.12048 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBrilene, Tatjana | |
245 | 0 | 0 |
_aIn vitro synergy of oxacillin and gentamicin against coagulase-negative staphylococci from blood cultures of neonates with late-onset sepsis. _h[electronic resource] |
260 |
_bAPMIS : acta pathologica, microbiologica, et immunologica Scandinavica _cSep 2013 |
||
300 |
_a859-64 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAnti-Bacterial Agents _xpharmacology |
650 | 0 | 4 |
_aBacterial Proteins _xgenetics |
650 | 0 | 4 |
_aCoagulase _xdeficiency |
650 | 0 | 4 | _aCulture Media |
650 | 0 | 4 | _aDrug Resistance, Bacterial |
650 | 0 | 4 | _aDrug Synergism |
650 | 0 | 4 | _aDrug Therapy, Combination |
650 | 0 | 4 |
_aGentamicins _xpharmacology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInfant, Newborn |
650 | 0 | 4 | _aMicrobial Sensitivity Tests |
650 | 0 | 4 |
_aOxacillin _xpharmacology |
650 | 0 | 4 |
_aSepsis _xmicrobiology |
650 | 0 | 4 |
_aStaphylococcal Infections _xmicrobiology |
650 | 0 | 4 |
_aStaphylococcus _xdrug effects |
650 | 0 | 4 |
_aVancomycin _xpharmacology |
700 | 1 | _aSoeorg, Hiie | |
700 | 1 | _aKiis, Merilin | |
700 | 1 | _aSepp, Epp | |
700 | 1 | _aKõljalg, Siiri | |
700 | 1 | _aLõivukene, Krista | |
700 | 1 | _aJürna-Ellam, Marika | |
700 | 1 | _aKalinina, Jelena | |
700 | 1 | _aStšepetova, Jelena | |
700 | 1 | _aMetsvaht, Tuuli | |
700 | 1 | _aLutsar, Irja | |
773 | 0 |
_tAPMIS : acta pathologica, microbiologica, et immunologica Scandinavica _gvol. 121 _gno. 9 _gp. 859-64 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/apm.12048 _zAvailable from publisher's website |
999 |
_c22397784 _d22397784 |